Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Jan 2022 – 20 Aug 2026, limited by Edelweiss Nifty 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Edelweiss Nifty 50 Index Fund | Nifty 50 |
|---|---|---|
| 28 Jan 2022 | ₹100.00 | ₹100.00 |
| 16 Jun 2022 | ₹90.12 | ₹89.82 |
| 02 Nov 2022 | ₹106.33 | ₹105.74 |
| 20 Mar 2023 | ₹99.71 | ₹99.34 |
| 06 Aug 2023 | ₹114.85 | ₹114.12 |
| 23 Dec 2023 | ₹125.77 | ₹124.84 |
| 10 May 2024 | ₹130.00 | ₹128.96 |
| 25 Sep 2024 | ₹153.61 | ₹152.05 |
| 11 Feb 2025 | ₹136.43 | ₹134.91 |
| 30 Jun 2025 | ₹151.37 | ₹149.21 |
| 16 Nov 2025 | ₹154.16 | ₹151.50 |
| 03 Apr 2026 | ₹135.09 | ₹132.81 |
| 20 Aug 2026 | ₹145.00 | ₹141.69 |
| Metric | Edelweiss · Regular · IDCW NAV ₹13.87 Very High risk ★★★★☆ | Category median Index Funds · 271 funds |
|---|---|---|
| -2.68% | +4.72% | |
| +8.41% | +7.52% | |
| — | +8.28% | |
| — | +9.00% | |
| +8.49% | +7.27% | |
| +6.84% | — | |
| +12.12% | +7.88% | |
| — | +10.94% | |
| — | +9.63% | |
| Risk | ||
| 13.16% | 13.54% | |
| 0.14 | 0.11 | |
| 0.20 | 0.15 | |
| -15.65% | -15.67% | |
| Nifty 50 | — | |
| +0.52% | -0.05% | |
| 0.99 | 1.00 | |
| 100.8% | 101.3% | |
| 97.6% | 99.5% | |
| 0.52% | 0.88% | |
| ₹286.17Cr | ₹181.49Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 2% | 38% | |
| Bhavesh Jain | — | |
| 28 Jan 2022 | — | |
| 50 | — | |
| 53.5% | — | |
| -0.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.